Explore
Validate
LearnHPA017019
antibody from Atlas Antibodies
Targeting: TGFBI
BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA017019 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA017019, RRID:AB_2669511
- Product name
- Anti-TGFBI
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human TGFBI, Gene description: transforming growth factor, beta-induced, 68kDa, Alternative Gene Names: BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1, Validated applications: IHC, WB, Uniprot ID: Q15582, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer
de la Fouchardière C, Gamradt P, Chabaud S, Raddaz M, Blanc E, Msika O, Treilleux I, Bachy S, Cattey-Javouhey A, Guibert P, Sarabi M, Rochefort P, Funk-Debleds P, Coutzac C, Ray-Coquard I, Peyrat P, Meeus P, Rivoire M, Dupré A, Hennino A
Journal of Personalized Medicine 2022;12(4):623
Journal of Personalized Medicine 2022;12(4):623
TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer
Lecker L, Berlato C, Maniati E, Delaine-Smith R, Pearce O, Heath O, Nichols S, Trevisan C, Novak M, McDermott J, Brenton J, Cutillas P, Rajeeve V, Hennino A, Drapkin R, Loessner D, Balkwill F
Cancer Research 2021;81(22):5706-5719
Cancer Research 2021;81(22):5706-5719
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human placenta and pancreas tissues using HPA017019 antibody. Corresponding TGFBI RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
